Anthem Biosciences Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Anthem Biosciences stock has a consensus rating of "Strong Buy" and an average price target of ₹879.43. The average 1-year stock price forecast is 11.17% higher than the current stock price, while the lowest is ₹830.00 (+4.92%) and the highest is ₹956.00 (+20.85%).

Price Target: ₹879.43 (+11.17%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	₹830.00	₹879.43	₹870.00	₹956.00
Change	+4.92%	+11.17%	+9.98%	+20.85%

* Price targets were last updated on May 22, 2026.

Analyst Ratings

The average analyst rating for Anthem Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	0	2	2	4	4	4
Buy	3	3	3	3	3	3
Hold	1	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	5	5	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Bansi Desai J.P. Morgan	J.P. Morgan	Buy Maintains ₹850.00	Buy	Maintains	₹850.00	+7.45%	May 22, 2026
Unknown Analyst Prabhudas Lilladher No rating	Prabhudas Lilladher	Buy Initiates ₹755.00	Buy	Initiates	₹755.00	-4.56%	Mar 30, 2026

Financial Forecast

Revenue This Year

25.72B

from 21.24B

21.06%

from 21.24B

Revenue Next Year

30.97B

from 25.72B

20.44%

from 25.72B

EPS This Year

12.93

from 10.74

20.37%

from 10.74

EPS Next Year

15.67

from 12.93

21.26%

from 12.93

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	12.41B	10.58B	14.20B	18.50B	21.24B	25.72B
Revenue Growth	12.24%	-14.74%	34.24%	30.29%	14.80%	21.06%
Gross Profit	8.14B	7.00B	7.95B	10.69B	13.12B	16.02B
Gross Margin	65.58%	66.21%	55.96%	57.77%	61.76%	62.30%
Operating Income	5.20B	3.72B	4.25B	5.88B	7.00B	8.60B
Net Income	4.06B	3.85B	3.67B	4.51B	5.92B	7.28B
EPS	-	-	-	-	10.74	12.93
EPS Growth	-	-	-	-	-	20.37%
Forward PE	-	-	-	-	54.93	61.20
Free Cash Flow	963.49M	305.50M	-2.19B	512.86M	5.51B	-477.20M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue	2027	2028	2029
High	26.6B
Avg	25.7B
Low	25.3B

Revenue Growth

Revenue Growth	2027	2028	2029
High	25.0%
Avg	21.1%
Low	19.3%

EPS Forecast

EPS	2027	2028	2029
High	-
Avg	12.93
Low	-

EPS Growth

EPS Growth	2027	2028	2029
High	-
Avg	20.4%
Low	-